In the past couple of years, Singapore cancer treatment
options have evolved significantly with the advancements in medical
technologies. Cancer/tumor profiling is an advanced investigative tool
that offers information about the genes causing cancer. This
information plays a vital role in enabling doctors to deliver more targeted
treatments to cancer patients.
Download Sample Report: https://www.alliedmarketresearch.com/request-sample/2717
Through Singapore tumor profiling, doctors
can determine which therapy is likely to be the most effective for
a particular patient. Starting from common cancers, such as breast cancer and carcinoma to molecular
profiling of acute leukemia, prostate cancer, and lung cancer can be achieved
through tumor profiling. Some molecular profiling tests may use one,
two, or an array of technologies such as immunohistochemistry (IHC),
Next Generation Sequencing (NGS), Sanger
Sequencing, Fragment
Analysis, or Pyro Sequencing to uncover information about the cancer.
The prevalence of
Singapore tumor profiling is rapidly increasing in the medical community globally. This
can be carried out relatively quickly i.e. within just one or two weeks after a
tissue sample has been obtained. To undertake biopsy of the tumor, the DNA
cells are extracted from the tumor and purified before being examined. The fluid used is often blood,
but may also be urine, mucus, saliva, tears, semen, or others.
Certain factors such
as surge in incidence of cancer across the globe, increase in adoption of cancer
biomarkers for tumor profiling, rise in demand for cancer profiling techniques
by oncologists for diagnosis or treatment of cancers, and growth in use of next
generation sequencing technique for tumor profiling are driving the growth of
the market in more than one way.
However, in 2020, the outbreak of the COVID-19
pandemic led to have a negative impact on the growth of the Singaporecancer/tumor
profiling market, especially in
the initial stage. This is attributed to the implementation of global lockdown
which cancelled or delayed several appointments for tumor profiling across the
world.
Nevertheless, China is providing lucrative opportunities for the growth of the market, owing to significant development of precision medicine in the country. With this drift on board, the Singapore cancer tumor profiling market is expected to recover in a steady pace while also gathering immense growth in the near future.
0 Comments